Data protection Impressum

Healthcare

Swiss start-ups raised CHF 2.9 billion in 2025, marking a strong recovery in venture capital investment led by ICT and biotech.

Business environment

Swiss start-ups attract CHF 2.9 billion in 2025 as venture capital rebounds

3 February 2026

SamanTree Medical has secured EUR 20 million from the European Investment Bank to expand its surgical imaging technology across Europe and the United States and accelerate product development.

SamanTree Medical secures EUR 20 million to scale surgical imaging technology

2 February 2026

ORamaVR has raised USD 4.5 million in late-seed funding to accelerate the commercial rollout of its AI-powered medical extended reality platform for surgical training and device simulation.

Geneva-based ORamaVR raises USD 4.5 million to scale medical XR training solutions

30 January 2026

DigeHealth has raised CHF 1.25 million to accelerate the development of a wearable device that continuously monitors gastrointestinal activity using acoustics and artificial intelligence.

DigeHealth raises CHF 1.25 million to advance continuous gastrointestinal monitoring

15 December 2025

Vaud has launched Vaud Talent Hub, a new platform designed to attract, integrate and retain skilled professionals as the canton addresses growing labor shortages.

Vaud launches new Talent Hub to strengthen its workforce attraction and retention

10 December 2025

Geneva has inaugurated its first AI health hub at Campus Biotech to advance AI-driven care, research and neurotechnology in Western Switzerland.

Geneva inaugurates its first AI health hub at Campus Biotech

8 December 2025

Inselspital Bern has performed its 300th CAR-T cell therapy treatment, underscoring Western Switzerland’s role as a leading center for advanced immuno-oncology.

Bern’s Inselspital marks a new era in personalized cancer treatment

8 December 2025

Researchers at CHUV have validated a new stem-cell–based method to study autoimmune diseases in organs such as the brain, offering new insights into conditions like autoimmune encephalitis and multiple sclerosis.

CHUV researchers develop new method to study autoimmune diseases

2 December 2025

Artiria Medical has received CE Mark certification for its SmartGUIDE 014 guidewire, enabling commercialization across Europe and expanding clinical adoption for stroke and aneurysm interventions.

Artiria Medical obtains CE Mark for its deflectable guidewire

2 December 2025

Takeda has opened a new CHF 200 million biotechnology facility in Neuchâtel to expand aseptic filling capacity for rare disease therapies.

Takeda inaugurates CHF 200 million biotechnology facility in Neuchâtel

1 December 2025

1 2 3 4 5 6 7 8 9 10 … 24